no abstract
Pantaleo, M.A., Nannini, M. (2016). Long-term outcome of molecular subgroups of gastrointestinal stromal tumour patients treated with standard-dose imatinib in the BFR14 trial: The wild-type gastrointestinal stromal tumours are not a single group yet. EUROPEAN JOURNAL OF CANCER, 58, 38-40 [10.1016/j.ejca.2016.01.018].
Long-term outcome of molecular subgroups of gastrointestinal stromal tumour patients treated with standard-dose imatinib in the BFR14 trial: The wild-type gastrointestinal stromal tumours are not a single group yet
PANTALEO, MARIA ABBONDANZA;NANNINI, MARGHERITA
2016
Abstract
no abstractFile in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.